The blood-brain barrier has confounded the development of many neurological treatments over the years. Now, several companies are claiming they can tackle the problem. Alan Dove reports.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dove, A. Breaching the barrier. Nat Biotechnol 26, 1213–1215 (2008). https://doi.org/10.1038/nbt1108-1213
Issue Date:
DOI: https://doi.org/10.1038/nbt1108-1213
- Springer Nature America, Inc.
This article is cited by
-
Incomplete copolymer degradation of in situ chemotherapy
Journal of Materials Science: Materials in Medicine (2018)